Global and United States Tuberculosis Vaccination Market Report & Forecast 2022-2028

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme
Market Analysis and Insights: Global and United States Tuberculosis Vaccination Market

This report focuses on global and United States Tuberculosis Vaccination market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Tuberculosis Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Immune Vaccine accounting for % of the Tuberculosis Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Self-Procurement was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Tuberculosis Vaccination market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Tuberculosis Vaccination Scope and Market Size

Tuberculosis Vaccination market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Tuberculosis Vaccination market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Tuberculosis Vaccination market is segmented into

Immune Vaccine

Therapy Vaccine

Segment by Application, the Tuberculosis Vaccination market is segmented into

Self-Procurement

UNICEF

Other

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Tuberculosis Vaccination Market Share Analysis

Tuberculosis Vaccination market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Tuberculosis Vaccination business, the date to enter into the Tuberculosis Vaccination market, Tuberculosis Vaccination product introduction, recent developments, etc.

The major vendors covered:

Merck

Japan BCG Lab

Serum Institute of India

AJ Vaccines

BioFarma

GreenSignal Bio Pharma

China National Biotec

Biomed Lublin

Taj Pharmaceuticals

Ataulpho de Paiva

IVAC – Institute of Vaccines and Medical Biologicals

Queen Saovabha Mem. Inst

Microgen